Trängningsinkontinens hos kvinnor
Senast uppdaterad: Senast reviderad:
Sakkunnig:Anna Nager
Definition:
Plötslig och starkt behov av att tömma urinblåsan, som oftast leder till en större mängd urinläckage.
Förekomst:
Ren trängningsinkontinens utgör cirka 10–15% av patienter med inkontinens.
Symtom:
Symtomen är plötslig och stark känsla av att tömma urinblåsan.
Kliniska fynd:
Den kliniska undersökningen är oftast normal.
Diagnostik:
Socialstyrelsen rekommenderar en basal utredning.
Behandling:
Behandlingen är blås- och bäckenbottenträning, ev. med läkemedel systemiskt eller lokalbehandling med östrogen.
- Norton P, Brubaker L. Urinary incontinence in women. Lancet 2006; 367: 57-67. PubMed
- SBU. Behandling av urininkontinens. En systematisk litteraturöversikt. Stockholm: Statens beredning för medicinsk utvärdering (SBU); 2000. SBU-rapport nr 143. ISBN 91-87890-56-9
- SBU, Behandling av urininkontinens hos äldre och sköra äldre - en systematisk litteraturöversikt, Oktober 2013
- O'Halloran T, Bell RJ, Robinson PJ, Davis SR. Urinary incontinence in young nulligravid women: A cross-sectional analysis. Ann Intern Med 2012; 157: 87-93. Annals of Internal Medicine
- Nygaard I, Turvey C, Burns TL, Crischilles E, Wallace R. Urinary incontinence and depression in middle-aged United States women. Obstet Gynecol 2003; 101: 149-56. PubMed
- Hannestad YS, Lie RT, Rørtveit G, Hunskaar S. Familial risk of urinary incontinence in women: population based cross sectional study. BMJ 2004; 329: 889-91. British Medical Journal
- Socialstyrelsen. Blåsdysfunktion hos äldre personer - Indikationer vid urininkontinens och andra symtom vid vård av äldre personer i särskilt boende eller hemsjukvård. : , 2016. www.socialstyrelsen.se
- Berghmans LC, Hendriks HJ, De Bie RA, van Waalwijk van Doorn ES, Bo K and van Kerrebroeck PE. Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials. BJU Int 2000; 85: 254-63. PubMed
- Weiss BD. Selecting medications for the treatment of urinary incontinence. Am Fam Physician 2005; 71: 315-22. American Family Physician
- Betmiga (mirabegron). Läkemedelsverket. Tryckt version: 2014;25(4). www.lakemedelsverket.se
- Holroyd-Leduc JM, Straus SE. Management of urinary incontinence in women: scientific review. JAMA 2004; 291: 986-95. Journal of the American Medical Association
- Rai BP, Cody JD, Alhasso A, Stewart L. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD003193. DOI: 10.1002/14651858.CD003193.pub4. DOI
- Gray S L, Anderson ML, Dublin S,et al. "Cumulative Use of Strong Anticholinergic Medications and Incident Dementia". JAMA Intern Med. 2015;175(3):401-407. PubMed. www.ncbi.nlm.nih.gov
- Burgio KL. Current perspectives on management of urgency using bladder and behavioral training. J Am Acad Nurse Pract 2004; 16 (10 suppl): 4-7.
- Wallace SA, Roe B, Williams K and Palmer M. Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev 2004; 1. The Cochrane Library
- Diokno AC, Burgio K, Fultz NH, Kinchen KS, Obenchain R and Bump RC. Medical and self-care practices reported by women with urinary incontinence. Am J Manag Care 2004; 10: 69-78. PubMed
- Hagen S, Elders A, Stratton S, et al. Effectiveness of pelvic floor muscle training with and without electromyographic biofeedback for urinary incontinence in women: multicentre randomised controlled trial. BMJ 2020. doi:10.1136/bmj.m3719 DOI
- Valtin H. "Drink at least eight glasses of water a day." Really? Is there scientific evidence for "8×8"?. Am J Physiol Regul Integr Comp Physiol 2002; 283: R993-R1004.
- Asklund I, Nyström E, Sjöström M, Umefjord G, Stenlund H, Samuelsson E. Mobile app for treatment of stress urinary incontinence: A randomized controlled trial. Neurourol Urodyn. 2017;36(5):1369–1376. PMID: 27611958 PubMed
- Van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A. Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology 2001; 57: 414-21. PubMed
- Appell RA, Sand P, Dmochowski R, Anderson R, Zinner N, Lama D, et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clin Proc 2001; 76: 358-63. PubMed
- Blonski J. Is tolterodine (Detrol) or oxybutynin (Ditropan) the best for treatment of urge urinary incontinence? J Fam Pract 2001; 50: 1017. PubMed
- Clemett D, Jarvis B. Tolterodine. A review of its use in the treatment of overactive bladder. Drugs & Aging 2001; 18: 277 - 304.
- Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003; 326: 841. PubMed
- Samuelsson E, Odeberg J, Stenzelius K et al. Effect of pharmacological treatment for urinary incontinence in the elderly and frail elderly: A systematic review. Geriatr Gerontol Int. 2015; 15(5): 521-34. pmid:25656412 PubMed
- Samuelsson E, Odeberg J, Stenzelius K, et al. Effect of pharmacological treatment for urinary incontinence in the elderly and frail elderly: A systematic review. Geriatr Gerontol Int 2015; 15: 521-34. doi:10.1111/ggi.12451 onlinelibrary.wiley.com
- Socialstyrelsen. Olämpliga läkemedel för äldre personer (2015). www.socialstyrelsen.se
- Todorova A, Vonderheid-Guth B, Dimpfel W. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 2001; 41: 636-44. PubMed
- Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD005493. DOI: 10.1002/14651858.CD005493.pub3. The Cochrane Library
- Visco AG, Brubaker L, Richter HE, et al.. Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence. N Engl J Med 2012. pmid:23036134. PubMed
- Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD001405. DOI: 10.1002/14651858.CD001405.pub3. DOI
- Hendrix SL, Cochrane BC, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005; 293: 935-48. Journal of the American Medical Association
- Cody JD, Richardson K, Moehrer B, et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2009; 4: CD001405. Cochrane (DOI)
- Wyman JF, Fantl JA. Bladder training in ambulatory care management of urinary incontinence. Urol Nurs 1991; 11: 11-7. PubMed
- Burgio KL, Goode PS, Locher JL, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women. JAMA 2003; 288: 2293-9. Journal of the American Medical Association
- Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc 2000; 48: 370-4. PubMed
- Riktlinjer för behandling av urininkontinens. Janusinfo, Region Stockholm. Hämtad 2020-10-27 janusinfo.se
- Janknegt RA, Hassouna MM, Siegel SW, Schmidt RA, Gajewski JB, Rivas DA, et al. Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol 2001; 39: 101-6. PubMed
- Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet
Tidigare sakkunniga
- Pia Teleman, docent och överläkare, VO kvinnosjukvård, Skånes universitetssjukhus